Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adverum Biotechnlgs (ADVM)

12.51   -2.39 (-16.04%) 08-13 16:00
Open: 12.85 Pre. Close: 14.9
High: 13.12 Low: 11.75
Volume: 10,900,832 Market Cap: 1,009M
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. Its pipeline of product candidates includes ADVM-022, an adeno- associated virus (AAV). 7m8-aflibercept for the treatment of wet age-related macular degeneration; ADVM-043, an investigational gene therapy candidate for the treatment of alpha-1 antitrypsin deficiency; and ADVM-053, a preclinical gene therapy product candidate for the treatment of hereditary angioedema. The company has collaboration agreements with Editas Medicine, Inc. to leverage its proprietary AAV vectors for genome editing technologies to treat up to five inherited retinal diseases; and Regeneron Pharmaceuticals, Inc. for the development of up to eight distinct ocular therapeutic targets. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.148 - 13.227 13.227 - 13.286
Low: 11.577 - 11.673 11.673 - 11.744
Close: 12.377 - 12.527 12.527 - 12.638

Technical analysis

as of: 2020-08-13 4:31:17 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 20.54     One year: 24.75
Support: Support1: 11.75    Support2: 9.78
Resistance: Resistance1: 17.58    Resistance2: 21.19
Pivot: 16.96
Moving Average: MA(5): 16.03     MA(20): 17.08
MA(100): 17.42     MA(250): 12.92
MACD: MACD(12,26): -1.12     Signal(9): -0.82
Stochastic oscillator: %K(14,3): 12.36     %D(3): 32.82
RSI: RSI(14): 28.11
52-week: High: 26.98  Low: 4.96  Change(%): -6.6
Average Vol(K): 3-Month: 128104  10-Days: 202578

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ADVM has closed below the lower band by 22.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 2.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 80
Shares Float (M) 51
% Held by Insiders 3.34
% Held by Institutions 80.01
Shares Short (K) 10,930
Shares Short P. Month (K) 11,840

Stock Financials

EPS -1.090
EPS Est This Year -1.260
EPS Est Next Year -1.310
Book Value (p.s.) 3.810
Profit Margin
Operating Margin -30651.60
Return on Assets (ttm) -16.8
Return on Equity (ttm) -29.6
Qtrly Rev. Growth
Gross Profit (p.s.) -0.500
Sales Per Share 0.003
EBITDA (p.s.) -0.933
Qtrly Earnings Growth
Operating Cash Flow (M) -50
Levered Free Cash Flow (M) -50

Stock Valuations

PE Ratio -11.48
PEG Ratio
Price to Book value 3.28
Price to Sales 4018.21
Price to Cash Flow -20.27

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.